News
- Author:
- Damian McNamara, MA
Publish date: October 27, 2023
Biologics infliximab, adalimumab, golimumab, certolizumab, vedolizumab, natalizumab, and ustekinumab not only did not increase risk, but they lower...
News
- Author:
- Damian McNamara, MA
Publish date: October 27, 2023
"This is the first large study to include the 45- to 49-year-old population, for whom screening is now recommended."
News
- Author:
- Damian McNamara, MA
Publish date: October 13, 2023
Investigators say their findings are not about scaring people off the weight-loss drugs, but instead about increasing awareness that these potentia...
News
- Author:
- Damian McNamara, MA
Publish date: August 31, 2023
“A challenge with COVID-19, all along, has been disparities in access to care, and this will be worse without public support for prevention and tes...
News
- Author:
- Damian McNamara, MA
Publish date: August 11, 2023
While the numbers are still low, compared with 2022’s summer surge, experts still urge people to stay aware of changes in the virus. “I do not...
News
- Author:
- Damian McNamara, MA
Publish date: August 10, 2023
“A fast-acting pill that can be taken orally could be an ideal option for the 15% to 20% of women who experience postpartum depression.”
News
- Author:
- Damian McNamara, MA
Publish date: August 9, 2023
Although the study is not the first to point to specific genes, “we were quite surprised by the proposed function of some of the genes we identifie...
News
- Author:
- Damian McNamara, MA
Publish date: June 20, 2023
Three-expert panel at DDW suggests clinicians should embrace the technology.
News
- Author:
- Damian McNamara, MA
Publish date: June 20, 2023
If approved by the FDA, etrasimod could become the second agent in the S1P class approved for ulcerative colitis in the United States.
News
- Author:
- Damian McNamara, MA
Publish date: June 9, 2023
The effects of smoke from wildfires can continue for many years.
News
- Author:
- Damian McNamara, MA
Publish date: May 30, 2023
“We still don’t have randomized trials where we’re looking at obesity phenotyping yet.”
News
- Author:
- Damian McNamara, MA
Publish date: May 12, 2023
A new device developed at Massachusetts Institute of Technology shows promise.
News
- Author:
- Damian McNamara, MA
Publish date: May 12, 2023
Findings are based on a pooled analysis of six randomized controlled trials from the past 10 years.
News
- Author:
- Damian McNamara, MA
Publish date: May 12, 2023
Some experts believe weight-loss medications can help with the rebound in weight that some people experience months after bariatric surgery.
News
- Author:
- Damian McNamara, MA
Publish date: May 3, 2023
New evidence points to a cycle wherein undifferentiated stem cells mature to perform their hair-coloring duties and then transform back to their pr...
